\
&
Contact us
\
&
Contact us
Published on | 3 years ago
Programmes EICFor the call European Innovation Council (EIC) Pathfinder Open 2021 (deadline 25 May 2021) in total 908 proposals were submitted, 868 evaluated and 56 proposals selected for funding, of which five with a coordinator based in Flanders:
- imec, project “QuMicro - Quantum Microwave Detection with Diamond Spins”
- Universiteit Antwerpen, project “PRINGLE - Protein-based next generation electronics”
- Universiteit Gent, project “CSOC - Chip-scale Optical Atomic Clock”
- Katholieke Universiteit Leuven, project “SynEry - Bottom-up reconstruction of a Synthetic Erythrocyte”
- Vrije Universiteit Brussel, project “VortexLC - Vortex enhanced liquid chromatography for HbA1c monitoring based diabetes management in a globalized setting”
More information on submission statistics and awarded projects can be found in this EIC news article
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
